African Journal of
Pharmacy and Pharmacology

  • Abbreviation: Afr. J. Pharm. Pharmacol.
  • Language: English
  • ISSN: 1996-0816
  • DOI: 10.5897/AJPP
  • Start Year: 2007
  • Published Articles: 2288

Full Length Research Paper

Artemisinin combination therapy use in Federal Capital Territory, Nigeria

Aboh M.
  • Aboh M.
  • National Institute for Pharmaceutical Research and Development, Department of Microbiology and Biotechnology, Abuja Nigeria.
  • Google Scholar
Emeje M.
  • Emeje M.
  • National Institute for Pharmaceutical Research and Development, Centre for Nanomedicine and Biophysical Drug delivery, Abuja, Nigeria.
  • Google Scholar
Oladosu P.
  • Oladosu P.
  • National Institute for Pharmaceutical Research and Development, Department of Microbiology and Biotechnology, Abuja Nigeria.
  • Google Scholar
Akah I.
  • Akah I.
  • National Institute for Pharmaceutical Research and Development, Department of Microbiology and Biotechnology, Abuja Nigeria.
  • Google Scholar
Gamaniel K.
  • Gamaniel K.
  • National Institute for Pharmaceutical Research and Development, Director -General’s Office Abuja, Nigeria.
  • Google Scholar


  •  Received: 04 March 2016
  •  Accepted: 25 August 2016
  •  Published: 15 October 2016

References

Afonso A, Hunt P, Cheesman S, Alves AC, Cunha CV, Do Rosário V, Cravo P (2006). Malaria parasites can develop stable resistance to artemisinin but lack mutations in candidate genes atp6 (encoding the sarcoplasmic and endoplasmic reticulum Ca2+ ATPase), tctp, mdr1, and cg10. Antimicrob. Agents Chemother. 50(2):480-489.
Crossref

 

Ajayi NA, Ukwaja KN (2013). Possible artemisinin-based combination therapy-resistant malaria in Nigeria: a report of three cases. Rev. Soc. Bras. Med. Trop. 46(4):525-527.
Crossref

 
 

Amponsah AO, Vosper H, Marfo AA (2015). Patient Related Factors Affecting Adherence to Antimalarial Medication in an Urban Estate in Ghana. Malar. Res. Treat. pp. 1-8.
Crossref

 
 

Chatio S, Aborigo R, Adongo PB, Anyorigiya T, Akweongo P, Oduro A (2015). Adherence and uptake of artemisinin- based combination treatments for uncomplicated malaria: A qualitative study in Northern Ghana. PLoSONE 10(2):1-14.
Crossref

 
 

El-Duah M, Ofori-Kwakye K (2012). Substandard artemisinin-based antimalarial medicines in licensed retail pharmaceutical outlets in Ghana. J Vector Borne Dis. 49:131-139.

 
 

Esimone CO, Okoye FBC, Onah BU, Nworu CS, Omeje EO (2008). In vitro bioequivalence study of nine brands of artesunate tablets marketed in Nigeria. J Vector Borne Dis. 45:60-65.

 
 

Ezenduka CC, Okonta MJ, Esimone CO (2014). Adherence to treatment guidelines for uncomplicated malaria at two public health facilities in Nigeria; Implications for the 'test and treat' policy of malaria case management. J. Pharmaceut. Policy Pract. 7:1-5.
Crossref

 
 

Ibekwe J (2009). Artemisinin resistant M#malaria on the horizon. Int. J. Med. Med. Sci. 1(6):1-3.

 
 

Khantikul N, Butraporn P, Kim HS, Leemingsawat S, Tempongko SB, Suwonkerd W (2009). Adherence to antimalarial drug therapy among Vivax Malaria Patients in Northern Thailand. J. Health Popul Nutr. 27(1):4-13.
Crossref

 
 

Mace KE, Mwandama D, Jafali J, Luka M, Filler SJ, Sande J, Ali D, Kachur SP, Mathanga DP, Skarbinski J (2011). Adherence to treatment with artemether-lumefantrine for uncomplicated malaria in rural Malawi. Clin. Infect. Dis. 53(8):772-779.
Crossref

 
 

Obidike IC, Okhale S, Aboh MI, Salawu OA (2013). Isolation, fractionation and evaluation of the antiplasmodial properties of Phyllanthus niruri resident in its chloroform fraction. Asian Pac. J. Trop. Med. 6(3):169-175.
Crossref

 
 

Osterberg L, Blaschke T (2005). Adherence to medication. N. Engl. J. Med. 353:487-497.
Crossref

 
 

President's Malaria Initiative Nigeria (2015). Malaria operational plan FY 2015 P 15.

 
 

World Health Organization (WHO) (2014). World Malaria Report 2014 FACT SHEET. Available: 

View Accessed 2014 Nov 3.

 
 

Wongsrichanalai C, Meshnick SR (2008). Declining artesunate-mefloquine efficacy against falciparum malaria on the Cambodia Thailand border. Emerg. Infect. Dis. 14:716-719.
Crossref